Details for New Drug Application (NDA): 215705
✉ Email this page to a colleague
The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 215705
Tradename: | SUCRALFATE |
Applicant: | Zydus Lifesciences |
Ingredient: | sucralfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 215705
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCRALFATE | sucralfate | TABLET;ORAL | 215705 | ANDA | REMEDYREPACK INC. | 70518-3959 | 70518-3959-0 | 30 TABLET in 1 BLISTER PACK (70518-3959-0) |
SUCRALFATE | sucralfate | TABLET;ORAL | 215705 | ANDA | Zydus Lifesciences Limited | 70771-1833 | 70771-1833-1 | 100 TABLET in 1 BOTTLE (70771-1833-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
Approval Date: | May 3, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription